These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6505042)

  • 1. First use of GdDTPA/dimeglumine in man.
    Laniado M; Weinmann HJ; Schörner W; Felix R; Speck U
    Physiol Chem Phys Med NMR; 1984; 16(2):157-65. PubMed ID: 6505042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.
    Weinmann HJ; Laniado M; Mützel W
    Physiol Chem Phys Med NMR; 1984; 16(2):167-72. PubMed ID: 6505043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contrast media in magnetic resonance tomography. A review. 1. Physicochemical and pharmacological bases of MR contrast media using gadolinium-DTPA as an example].
    Felix R; Semmler W; Schörner W; Laniado M
    Rofo; 1985 Jun; 142(6):641-6. PubMed ID: 2988062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.
    Weinmann HJ; Brasch RC; Press WR; Wesbey GE
    AJR Am J Roentgenol; 1984 Mar; 142(3):619-24. PubMed ID: 6607655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-DTPA: a new contrast agent for magnetic resonance imaging.
    Niendorf HP; Felix R; Laniado M; Schörner W; Claussen C; Weinmann HJ
    Radiat Med; 1985; 3(1):7-12. PubMed ID: 4070676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
    Goldstein HA; Kashanian FK; Blumetti RF; Holyoak WL; Hugo FP; Blumenfield DM
    Radiology; 1990 Jan; 174(1):17-23. PubMed ID: 2403679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance arthrography of the scapulohumeral joint in dogs, using gadopentetate dimeglumine.
    van Bree H; Van Ryssen B; Degryse H; Ramon F
    Am J Vet Res; 1995 Mar; 56(3):286-8. PubMed ID: 7771693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nuclear magnetic resonance tomography of the orbits. Initial experiences using the paramagnetic contrast medium gadolinium-DTPA].
    Markl A; Riedel KG; Oeckler R; Vogl T; Scheidhauer K
    Digitale Bilddiagn; 1986 Dec; 6(4):151-5. PubMed ID: 3816049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)].
    Gowin W; Weihe W; Appel C; Mariss G
    Rontgenpraxis; 1986 Nov; 39(11):367-77. PubMed ID: 3810314
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
    Giovagnoni A; Paci E
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ideal imaging in MR: contrast-enhancing pharmaceuticals. Evaluation of tempo carboxylic acid as nitroxide diagnostic agent.
    Lamarque JL; Almès C; Rouanet JP; Prat X; Bruel JM; Pujol J; Rodière MJ; Martin JM; Lopez P; Rossi M
    Eur J Radiol; 1986 Feb; 6(1):48-52. PubMed ID: 3699037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some aspects of the use of contrast agents in magnetic resonance imaging.
    Niendorf HP; Semmler W; Laniado M; Felix R
    Diagn Imaging Clin Med; 1986; 55(1-2):25-36. PubMed ID: 3011346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gadolinium-DTPA dimeglumine administered orally for the study of the abdomen with magnetic resonance. Clinical evaluation and tolerance].
    Squillaci E; Crecco M; Cecconi L; Lupoi D; Sergiacomi GL; Simonetti G
    Radiol Med; 1993 Sep; 86(3):284-93. PubMed ID: 8210538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced gradient-echo MR imaging of the head and neck: experimental and clinical assessment.
    Mihara F; Gupta KL; Joslyn JN
    Radiat Med; 1994; 12(4):147-51. PubMed ID: 7809407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [1st clinical use of gadolinium-DTPA in the nuclear magnetic resonance tomography visualization of a parapelvic kidney cyst].
    Schörner W; Laniado M; Felix R
    Rofo; 1984 Aug; 141(2):227-8. PubMed ID: 6431551
    [No Abstract]   [Full Text] [Related]  

  • 17. Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt University.
    Runge VM; Clanton JA; Price AC; Herzer WA; Wehr CJ; Lukehart CM; Partain CL; James AE
    Physiol Chem Phys Med NMR; 1984; 16(2):113-22. PubMed ID: 6438656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Gd-dimeglumine on subcutaneous tissues: a study with rats.
    McAlister WH; McAlister VI; Kissane JM
    AJNR Am J Neuroradiol; 1990; 11(2):325-7. PubMed ID: 2107714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine.
    Knopp MV; Giesel FL; von Tengg-Kobligk H; Radeleff J; Requardt M; Kirchin MA; Hentrich HR
    J Magn Reson Imaging; 2003 Jun; 17(6):694-702. PubMed ID: 12766899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.